Alexis Borisy is a successful biotechnology entrepreneur with more than 20 years of experience building and operating innovative science-based organizations. Alexis was most recently a partner at Third Rock Ventures, where he focused on the formation, development, and strategy of new companies. Prior to joining Third Rock Ventures, Alexis founded CombinatoRx in 2000, serving as its CEO and bringing the company public on the NASDAQ. He has raised billions in financing and business development deals and has authored numerous scientific papers and patents. Trained in chemistry and chemical biology at Harvard where he was a Howard Hughes Predoctoral Fellow, Alexis was honored as the Massachusetts Institute of Technology’s Technology Review Innovator of the Year. He was also chosen as the New England Entrepreneur of the Year in Life Sciences and was honored as a Presidential Scholar. Alexis is a trustee of the Boston Museum of Science, is a co-founder and former chairman of FORMA Therapeutics, and serves on the board of the National Venture Capital Association. Alexis earned his undergraduate degree in chemistry from the University of Chicago and conducted graduate work in the laboratory of Dr. Stuart Schreiber at Harvard University.